Cartesian Therapeutics

RNAC

NASDAQHealth Care

Income Statement

Total Revenue$38.91M

Gross Profit$38.91M

Operating Income$-43.9M

EBITDA$-73.55M

EBIT$-77.14M

Pre-tax Income$-160.97M

Net Income$-77.42M

Cash Equivalent$155.61M

Total Debt$13.49M

Book Value$-56.08M

Book Value Per Share-3.08

Return on Equity (ROE)+37.71%

Return on Assets (ROA)-17.80%

Return on Invested Capital (ROI)+29.46%

Net Profit Margin-198.97%

Current Ratio9.43

Quick Ratio9.29

Long-Term Debt / Equity0.19